Phosphodiesterase 5 inhibitor ameliorates renal resistance to atrial natriuretic peptide associated with obesity and hyperleptinemia

Archives of Medical Research

Volumn 37, Issue 3, 2006, Pages 307-315

  Beltowski, Jerzy ^a   Jamroz Wisniewska, Anna ^a   Borkowska, Ewelina ^a   Marciniak, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arterial hypertension; Atrial natriuretic peptide; Leptin; Natriuresis; Obesity

Indexed keywords

8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; CYCLIC GMP; ENKEPHALINASE INHIBITOR; LEPTIN; N ACETYL S NITROSOPENICILLAMINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PHOSPHORAMIDON; SODIUM; ZAPRINAST;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG POTENTIATION; HYPERLEPTINEMIA; KIDNEY MEDULLA; MALE; NATRIURESIS; NONHUMAN; OBESITY; PROTEIN METABOLISM; RAT; SODIUM EXCRETION; URINARY EXCRETION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DRUG RESISTANCE; HYPERLIPIDEMIAS; KIDNEY; MALE; OBESITY; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, WISTAR; SODIUM;

EID: 33644592667     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.06.008     Document Type: Article

References (50)

1. J.E. Hall Mechanisms of abnormal renal sodium handling in obesity hypertension Am J Hypertens 10 1997 49S 55S
2. J.E. Hall The kidney, hypertension, and obesity Hypertension 41 2003 625 633
3. M. Becker, D. Umrani, M.F. Lokhandwala, and T. Hussain Increased renal angiotensin II AT1 receptor function in obese Zucker rat Clin Exp Hypertens 25 2003 35 47
4. A. Marwaha, and M.F. Lokhandwala Diminished natriuretic response to dopamine D1 receptor agonist, SKF-38393 in obese Zucker rats Clin Exp Hypertens 25 2003 509 515
5. M.L. Correia, and W.G. Haynes Leptin, obesity and cardiovascular disease Curr Opin Nephrol Hypertens 13 2004 215 223
6. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Aidas Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, and J.F. Caro Serum immunoreactive-leptin concentrations in normal-weight and obese humans N Engl J Med 334 1996 292 295
7. E.W. Shek, M.W. Brands, and J.E. Hall Chronic leptin infusion increases arterial pressure Hypertension 31 1998 409 414
8. J. Agata, A. Masuda, M. Takada, K. Higashiura, H. Murakami, Y. Miyazaki, and K. Shimamoto High plasma immunoreactive leptin level in essential hypertension Am J Hypertens 10 1997 1171 1174
9. M. Zanetti, R. Barazzoni, M. Vadori, M. Stebel, G. Biolo, and G. Guarnieri Lack of direct effect of moderate hyperleptinemia to improve endothelial function in lean rat aorta: role of calorie restriction Atherosclerosis 175 2004 253 259
10. +-ATPase: the possible novel mechanism of leptin-induced hypertension Pol J Pharmacol 56 2004 213 222
11. +-ATPase activity in the rat - impaired effect in dietary-induced obesity Med Sci Monit 8 2002 BR221 BR229
12. M. McKee, C. Scavone, and J.A. Nathanson Nitric oxide, cGMP, and hormone regulation of active sodium transport Proc Natl Acad Sci USA 91 1994 12056 12060
13. C. Scavone, C. Scanlon, M. McKee, and J.A. Nathanson Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase J Pharmacol Exp Ther 272 1995 1036 1043
14. +-ATPase inhibition by atrial natriuretic factor in rat renal medulla J Physiol Pharmacol 49 1998 271 283
15. +-ATPase activity through cyclic GMP-protein kinase G dependent mechanism J Physiol Pharmacol 54 2003 191 210
16. K.R. Wong, M.H. Xie, L.B. Shi, F.Y. Liu, C.L. Huang, D.G. Gardner, and M.G. Cogan Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor Am J Physiol 255 1988 F1220 F1224
17. B. Lewko, U. Wendt, M. Szczepanska-Konkel, J. Stepinski, K. Drewnowska, and S. Angielski Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli Kidney Int 52 1997 654 659
18. G. De Pergola, G. Garruti, F. Giorgino, M.R. Cospite, M. Corso, M. Cignarelli, and R. Giorgino Reduced effectiveness of atrial natriuretic factor in pre-menopausal obese women Int J Obes Relat Metab Disord 18 1994 93 97
19. P. Dessi-Fulgheri, R. Sarzani, M. Serenelli, P. Tamburrini, D. Spagnolo, L. Giantomassi, E. Espinosa, and A. Rappelli Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives Hypertension 33 1999 658 662
20. +-ATPase activity Acta Biochim Pol 49 2002 515 527
21. R.O. Hurst The determination of nucleotide phosphorus with a stannous chloride-hydrazine sulfate reagent Can J Biochem 42 1964 287 292
22. O.H. Lowry, N.J. Rosebrough, A.l. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
23. P.A. Ortiz, and J.L. Garvin Role of nitric oxide in the regulation of nephron transport Am J Physiol Renal Physiol 282 2002 F777 F784
24. A. Charloux, F. Piquard, S. Doutreleau, G. Brandenberger, and B. Geny Mechanisms of renal hyporesponsiveness to ANP in heart failure Eur J Clin Invest 33 2003 769 778
25. H. Ruskoaho Atrial natriuretic peptide: synthesis, release, and metabolism Pharmacol Rev 44 1992 479 602
26. T.P. Dousa Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney Kidney Int 55 1999 29 62
27. E.G. McMahon, M.A. Palomo, P. Mehta, and G.M. Olins Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3′,5′- monophosphate-selective phosphodiesterase inhibitor J Pharmacol Exp Ther 251 1989 1000 1005
28. S.W. John, A.T. Veress, U. Honrath, C.K. Chong, L. Peng, O. Smithies, and H. Sonnenberg Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP Am J Physiol 271 1996 R109 R114
29. U. Honrath, C.K. Chong, L.G. Melo, and H. Sonnenberg Effect of saline infusion on kidney and collecting duct function in atrial natriuretic peptide (ANP) gene "knockout" mice Can J Physiol Pharmacol 77 1999 454 457
30. P. Dessi-Fulgheri, R. Sarzani, P. Tamburrini, A. Moraca, E. Espinosa, G. Cola, L. Giantomassi, and A. Rappelli Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients J Hypertens 15 1997 1695 1699
31. B. Baranowska, E. Wasilewska-Dziubinska, M. Radzikowska, A. Plonowski, and K. Roguski Impaired response of atrial natriuretic peptide to acute water load in obesity and in anorexia nervosa Eur J Endocrinol 132 1995 147 151
32. D.L. Crandall, G.D. Ferraro, and P. Cervoni Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide Proc Soc Exp Biol Med 191 1989 352 356
33. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, P.W. Wilson, and R.S. Vasan Impact of obesity on plasma natriuretic peptide levels Circulation 109 2004 594 600
34. M. Knecht, I. Pagel, T. Langenickel, S. Philipp, M. Scheuermann- Freestone, T. Willnow, D. Bruemmer, K. Graf, R. Dietz, and R. Willenbrock Increased expression of renal neutral endopeptidase in severe heart failure Life Sci 71 2002 2701 2712
35. R. Sarzani, V.M. Paci, C.M. Zingaretti, C. Pierleoni, S. Cinti, G. Cola, A. Rappelli, and P. Dessi-Fulgheri Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue J Hypertens 13 1995 1241 1246
36. J.P. Valentin, W.Z. Ying, L.A. Sechi, K.T. Ling, C. Qiu, W.G. Couser, and M.H. Humphreys Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis J Am Soc Nephrol 7 1996 582 593
37. J.P. Valentin, C. Qiu, W.P. Muldowney, W.Z. Ying, D.G. Gardner, and M.H. Humphreys Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome J Clin Invest 90 1992 1302 1312
38. L.L. Norling, B.A. Thornhill, and R.L. Chevalier Abnormal glomerular response to atrial natriuretic peptide in rats with aortocaval fistulas J Am Soc Nephrol 7 1996 1038 1044
39. T. Supaporn, S.M. Sandberg, D.D. Borgeson, D.M. Heublein, A. Luchner, C.M. Wei, T.P. Dousa, and J.C. Burnett Jr. Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure Kidney Int 50 1996 1718 1725
40. X.P. Ni, M. Safai, R. Rishi, C. Baylis, and M.H. Humphreys Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat J Am Soc Nephrol 15 2004 1254 1260
41. X. Ni, Y. Cheng, L. Cao, D.G. Gardner, and M.H. Humphreys Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation J Am Soc Nephrol 7 1996 2110 2118
42. X.P. Ni, M. Safai, D.G. Gardner, and M.H. Humphreys Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation Kidney Int 59 2001 1264 1273
43. E.Y. Lee, and M.H. Humphreys Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention Am J Physiol 271 1996 F3 F6
44. T. Hussain, S.A. Beheray, and M.F. Lokhandwala Defective dopamine receptor function in proximal tubules of obese Zucker rats Hypertension 34 1999 1091 1096
45. A.A. Banday, M. Asghar, T. Hussain, and M.F. Lokhandwala Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin Hypertension 41 2003 1353 1358
46. U. Holtback, H. Brismar, G.F. DiBona, M. Fu, P. Greengard, and A. Aperia Receptor recruitment: a mechanism for interactions between G protein-coupled receptors Proc Natl Acad Sci USA 96 1999 7271 7275
47. S.D. Rybalkin, C. Yan, K.E. Bornfeldt, and J.A. Beavo Cyclic GMP phosphodiesterases and regulation of smooth muscle function Circ Res 93 2003 280 291
48. F.J. Rivero-Vilches, S. de Frutos, M. Saura, D. Rodriguez-Puyol, and M. Rodriguez-Puyol Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP Am J Physiol Cell Physiol 285 2003 C891 C898
49. V. Millul, D. Prie, M. Geniteau-Legendre, M.C. Verpont, B. Baudouin, and P.M. Ronco ANP-stimulated cGMP egression in renal principal cells: abrogation of polarity by SV40 large T Am J Physiol 270 1996 C1051 C1060
50. - and is diminished by a high-salt diet Am J Physiol Renal Physiol 287 2004 F224 F230